LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/In Texas, Certain Docs May Bypass Prior Authorization
Legal & Regulatory and Reimbursement

In Texas, Certain Docs May Bypass Prior Authorization

September 17, 2021 2 min read Premium comments

Advertisement

#priorauthorization#housebill3459

Starting this month, many Texas physicians, including orthopedists, will no longer have to wait on prior authorization from health insurance companies to treat patients.

Texas House Bill 3459 was passed on June 18, 2021, and officially went into effect on September 1, 2021. The bill was sponsored by the following: Texas Representative Greg Bonnen, M.D.; Texas Representative Penny Morales Shaw; and Texas Senator Dawn Buckingham, M.D.

Dr. Bonnen wrote the bill. He is a neurosurgeon with Houston Physicians’ Hospital in Webster, Texas. Dr. Bonnen specializes in spine surgery and movement disorders.

Now, certain physicians can earn a “gold card” exemption from certain prior authorization review requirements. Physicians achieve gold card status by having a track record of prior approvals from insurers or HMOs. In addition to the gold card provisions, the new law also requires that Texas specialists perform the prior authorization review. Previously, this could be done by out-of-state physicians.

Physicians in support of the legislation spoke out about unnecessary delays in patient care. A Texas Orthopaedic Association infographic calling for legislative reforms on prior authorizations stated, “For nearly 1 [one] in 5 [five] patients who sought an orthopaedic procedure or surgery through TSAOG Orthopaedics in 2020, insurance requests for additional clinical data routinely delayed a healthcare decision by one week or more.”

The Texas Medical Association, based in Austin, Texas, is the largest state medical society in the country. It represents over 55,000 physician and medical student members. According to the Texas Medical Association, “Eight in 10 Texas physicians reported having to obtain prior authorization for medical procedures and even common, generic prescriptions. Four-fifths (85%) reported prior authorizations delayed patient care, often leading to an adverse event for their patient.”

Not all groups supported the bill. Insurance companies opposed the law, claiming it puts patients at risk and is burdensome to implement. The Texas Association of Health Plans CEO Jamie Dudensing spoke out against the legislation. The Texas Association of Health Plans is the statewide trade association. It represents health insurers, Medicaid plans, Medicare Advantage plans, and other Texas health care entities.

In one interview, Dudensing commented, “A lot of time what goes on with patient safety isn’t really just what happens with one physician. Health plans tend to be one of the few entities watching a patient’s role in health care where you have a 360 degree view of what’s happening.”

Dudensing also discussed the potential costs and difficulties with implementing the legislation, stating, “The bill was constructed in such a way that makes it almost impossible to implement. So instead of implementing gold carding, it’s really likely that most plans are just going to eliminate prior authorizations.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy